{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:55:56Z","timestamp":1791204956643,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.jns.2008.02.016","type":"journal-article","created":{"date-parts":[[2008,4,29]],"date-time":"2008-04-29T16:13:00Z","timestamp":1209485580000},"page":"99-106","source":"Crossref","is-referenced-by-count":53,"title":["Effect of 21-day exposure of phenobarbital, carbamazepine and phenytoin on P-glycoprotein expression and activity in the rat brain"],"prefix":"10.1016","volume":"270","author":[{"given":"Tao","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Ji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2008.02.016_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-1211(98)00106-5","article-title":"Clinical aspects and biological bases of drug-resistant epilepsies","volume":"34","author":"Regesta","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jns.2008.02.016_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/jpet.301.1.7","article-title":"Role of multidrug transporters in pharmacoresistance to antiepileptic drugs","volume":"301","author":"L\u00f6scher","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jns.2008.02.016_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1995.tb01657.x","article-title":"MDR1 gene expression in brain of patients with medically intractable epilepsy","volume":"36","author":"Tishler","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2008.02.016_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/brain\/awf002","article-title":"Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy","volume":"125","author":"Sisodiya","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jns.2008.02.016_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1525-5050(02)00557-7","article-title":"Does P-glycoprotein play a role in pharmacoresistance to antiepileptic drugs?","volume":"3","author":"Rogawski","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jns.2008.02.016_bib6","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1046\/j.1528-1157.2001.12301.x","article-title":"Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy","volume":"42","author":"Dombrowski","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2008.02.016_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nbd.2006.06.014","article-title":"The multidrug transporter hypothesis of drug resistance in epilepsy: proof-of-principle in a rat model of temporal lobe epilepsy","volume":"24","author":"Brandt","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2008.02.016_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1528-1167.2006.00496.x","article-title":"Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats","volume":"47","author":"van Vliet","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2008.02.016_bib9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neuropharm.2007.07.012","article-title":"Increased P-glycoprotein expression and decreased phenobarbital distribution in the brain of pentylenetetrazole-kindled rats","volume":"53","author":"Liu","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2008.02.016_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1369\/jhc.4A6451.2005","article-title":"Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables","volume":"53","author":"Volk","year":"2005","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jns.2008.02.016_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.neuroscience.2003.10.012","article-title":"Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures","volume":"123","author":"Volk","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2008.02.016_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eplepsyres.2003.12.009","article-title":"Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats","volume":"58","author":"Volk","year":"2004","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jns.2008.02.016_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CPP38069","article-title":"P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs","volume":"38","author":"Fromm","year":"2000","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jns.2008.02.016_bib14","doi-asserted-by":"crossref","first-page":"PL47","DOI":"10.1016\/S0024-3205(99)00599-8","article-title":"Increased brain P-glycoprotein in morphine tolerant rats","volume":"66","author":"Aquilante","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.jns.2008.02.016_bib15","first-page":"F832","article-title":"Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter","volume":"277","author":"Demeule","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jns.2008.02.016_bib16","first-page":"3352","article-title":"Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin","volume":"5","author":"Abolhoda","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jns.2008.02.016_bib17","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1523\/JNEUROSCI.22-14-05833.2002","article-title":"Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance","volume":"22","author":"Rizzi","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2008.02.016_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-2999(02)02235-5","article-title":"Lack of effects of prolonged treatment with phenobarbital or phenytoin on the expression of P-glycoprotein in various rat brain regions","volume":"451","author":"Seegers","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jns.2008.02.016_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eplepsyres.2006.10.003","article-title":"Effect of antiepileptic drugs on spontaneous seizures in epileptic rats","volume":"73","author":"Nissinen","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jns.2008.02.016_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1358\/mf.2002.24.3.802299","article-title":"Effect of melatonin and phenytoin on an intracortical ferric chloride model of posttraumatic seizures in rats","volume":"24","author":"Srivastava","year":"2002","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.jns.2008.02.016_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00210-004-0953-2","article-title":"Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate-induced seizures in rats","volume":"370","author":"Yamashita","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jns.2008.02.016_bib22","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1128\/AAC.45.12.3462-3467.2001","article-title":"Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats","volume":"45","author":"Ando","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jns.2008.02.016_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.brainres.2006.09.061","article-title":"Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats","volume":"1123","author":"Liu","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2008.02.016_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0306-4522(02)00992-2","article-title":"Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors","volume":"118","author":"Aronica","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2008.02.016_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.0013-9580.2004.57703.x","article-title":"Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy","volume":"45","author":"Aronica","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2008.02.016_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1528-1157.2003.42802.x","article-title":"Widespread upregulation of drug-resistance proteins in fatal human status epilepticus","volume":"44","author":"Sisodiya","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2008.02.016_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/074873002129002410","article-title":"Analysis of immunohistochemical label of Fos protein in the suprachiasmatic nucleus: comparison of different methods of quantification","volume":"17","author":"Rieux","year":"2002","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.jns.2008.02.016_bib28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1248\/bpb.29.779","article-title":"Relationship between excretion clearance of rhodamine 123 and P-glycoprotein (Pgp) expression induced by representative Pgp inducers","volume":"29","author":"Kageyama","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jns.2008.02.016_bib29","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.bcp.2006.02.004","article-title":"Effect of culture conditions on the expression and function of Bsep, Mrp2, and Mdr1a\/b in sandwich-cultured rat hepatocytes","volume":"71","author":"Turncliff","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jns.2008.02.016_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","article-title":"Blood-brain barrier active efflux transporters: ATP-binding cassette gene family","volume":"2","author":"L\u00f6scher","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.jns.2008.02.016_bib31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.leukres.2003.10.015","article-title":"Evaluation and comparison of MRP1 activity with three fluorescent dyes and three modulators in leukemic cell lines","volume":"28","author":"Dogan","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.jns.2008.02.016_bib32","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1042\/BJ20040355","article-title":"Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding","volume":"382","author":"Alqawi","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.jns.2008.02.016_bib33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/sj.bjp.0706830","article-title":"The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver","volume":"149","author":"Eyal","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jns.2008.02.016_bib34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/jpet.103.054197","article-title":"Interaction of antiepileptic drugs with human P-glycoprotein in vitro","volume":"307","author":"Weiss","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jns.2008.02.016_bib35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm1074","article-title":"The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions","volume":"10","author":"Rogawski","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jns.2008.02.016_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pharmthera.2006.07.005","article-title":"Novel anticonvulsant drugs","volume":"113","author":"Stefan","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jns.2008.02.016_bib37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1745-7254.2006.00246.x","article-title":"Transport of carbamazepine and drug interactions at blood-brain barrier","volume":"27","author":"Sun","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jns.2008.02.016_bib38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuropharm.2006.07.038","article-title":"Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein","volume":"52","author":"Baltes","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2008.02.016_bib39","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/pr.55.4.2","article-title":"Induction of drug metabolism: the role of nuclear receptors","volume":"55","author":"Handschin","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jns.2008.02.016_bib40","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/dmd.106.014456","article-title":"Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways","volume":"35","author":"Cerveny","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jns.2008.02.016_bib41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.106.112136","article-title":"Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers","volume":"320","author":"Faucette","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jns.2008.02.016_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clpt.2004.04.011","article-title":"Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans","volume":"76","author":"Giessmann","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jns.2008.02.016_bib43","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1124\/dmd.106.012005","article-title":"Phenytoin induction of the cyp2c37 gene is mediated by the constitutive androstane receptor","volume":"34","author":"Jackson","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jns.2008.02.016_bib44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1124\/jpet.103.058818","article-title":"Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor","volume":"308","author":"Chen","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jns.2008.02.016_bib45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2125.2006.02587.x","article-title":"Induction of P-glycoprotein in lymphocytes by carbamazepine and rifampicin: the role of nuclear hormone response elements","volume":"62","author":"Owen","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jns.2008.02.016_bib46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0026-895X(24)05623-2","article-title":"Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier","volume":"66","author":"Bauer","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jns.2008.02.016_bib47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2125.2001.01359.x","article-title":"Carbamazepine is not a substrate for P-glycoprotein","volume":"51","author":"Owen","year":"2001","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08000944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08000944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T23:22:39Z","timestamp":1738192959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X08000944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0022510X08000944"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2008.02.016","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}